A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
Clinical trial NCT05851443 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05851443
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-11
- Primary completion
- 2026-11-20
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.